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Abstract  
Integration of sexual  and reproductive health within HIV care services is a promising 
strategy for increasing access to family planning and STI services and reducing unwanted 
pregnancies, perinatal HIV transmission and maternal and infant mortality among people 
living with HIV and their partners. We conducted a Phase II randomized futility trial of 
a multi-level intervention to increase adherence to safer sex guidelines among those 
wishing to avoid pregnancy and adherence to safer conception guidelines among those 
seeking conception in newly-diagnosed HIV-positive persons in four public-sector HIV 
clinics in Cape Town. Clinics were pair-matched and the two clinics within each pair were 
randomized to either a three-session provider-delivered enhanced intervention (EI) 
(onsite contraceptive services and brief milieu intervention for staff) or standard-of-care 
(SOC) provider-delivered intervention. The futility analysis showed that we cannot rule out 
the possibility that the EI intervention has a 10 % point or greater success rate in improving 
adherence to safer sex/safer conception guidelines than does SOC (p = 0.573), indicating 
that the intervention holds merit, and a larger-scale confirmatory study showing whether 
the EI is superior to SOC has merit. 
 
Introduction 
For more than 20 years there have been calls for the integration of sexual and reproductive 
health (SRH) and HIV services [1–11]. SRH and HIV integration was cast as a key strategy  to  
meeting  the  2015  Millennium  Development Goals [12] in the U.S. President’s 
Emergency Plan for AIDS Relief (PEPFAR) [13] and in the 2016 United Nations General 
Assembly Political Declaration Zero Draft fast track agenda for sustainable development 
[14]. In sub-Saharan Africa, where reproductive-aged women bear a disproportionate 
burden of HIV, and both HIV-infected women and men are living longer, integration of 
SRH and HIV services in this era of combination therapy needs to be a priority. Differences 
in fertility intentions and fertility rates between HIV-positive and HIV-negative women 
are narrowing due to wider availability of antiretroviral therapy (ART), and the resulting 
improved health outcomes and life expectancy of people living with HIV (PLWH) [10, 
15–21]. 
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High rates of unmet contraceptive need and unintended pregnancy are common among 
the estimated 13 million women living with HIV in sub-Saharan Africa [22–24] 
Unintended pregnancies account for 14–58 % of all births in countries where the burden 
of HIV is the greatest [25]. One 2012 South African study found that 62 % of 
pregnancies among HIV-positive women at public-sector ART clinics were unintended 
[26], while a 2009 South African study reported that among women on ARVs, 9 % 
reported having been pregnant since initiating treatment, and 30 % of these pregnancies 
were unintentional [27]. Studies of contraceptive use among women living with HIV 
show contradictory findings, with some reporting low use of any form of contraception 
[20], others reporting increased use [28, 29] ], and in some countries, there is no 
relationship between HIV status and contraceptive use [19]. 
 
The benefits of SRH-HIV linkage have been documented in two systematic reviews 
[30–32]. A growing body of research indicates that integration of SRH and HIV services 
has the potential to increase access to family planning and STI prevention services, 
uptake of effective contraception and condom use among those who do not want to 
conceive [29, 33, 34], ART initiation during pregnancy, as well as to improve HIV 
testing rates and quality of services, and reduce unwanted pregnancies, perinatal HIV 
transmission and  maternal and infant mortality [6, 7, 17, 35–39]. However, there is little 
consensus on how integration is  operationalized and how best to integrate these 
services. Some integration models are a one-stop service that combine previously 
separate components of care, and add new components into existing services [34], while 
others use referral-based models. Other programs have integrated SRH into ARV 
services [37, 38] immediately prior to ART initiation rather than after initial linkage to 
HIV care. Most notably, empirical evidence is  still  limited [28, 29, 33, 34, 36] and often 
inconsistent [39], as noted in the studies below. 
 
The  Integra  Initiative,  which  assessed  the  impact  of different models of delivering 
integrated HIV-SRH service delivery in 40 health facilities in Kenya and Swaziland on 
service and health outcomes, found mixed effects in terms of technical efficiency of service 
delivery [40, 41]. Number of HIV and STI services in maternal and child health units, public 
ownership, and facility type resulted in positive effects on technical efficiency of service 
delivery, but number of HIV services in the same clinical room, relative number of clinical 
staff to overall staff, proportion of HIV services provided in facility, and rural location had 
negative effects on technical efficiency of integrated HIV-SRH services [41]. Another 
analysis of these data that quantified the extent and type of integration between HIV and 
SRH services in Kenya and Swaziland suggested that both structural integration 
(infrastructure and multi-tasking providers in same facility) and functional integration 
(delivery of care to clients in one place at one time) are needed for effective integration of 
these services to clients [34]. In the Swaziland Integra Initiative sites, a clinic-level 
evaluation found that integrating HIV testing and treatment into family planning and 
postnatal care, or providing on-site SRH services at an ARV site did not address 
reproductive health needs of PLWH any better than stand-alone clinics, with multiple 
organizational and provider factors affecting integration [42]. 
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However, other studies have found positive effects of integration. A pilot study of  a one-
stop shop model in Malawi comparing contraceptive prevalence in clinics before and after 
family planning service integration found that a clinic that integrated family planning into 
ART services increased non-pregnant women’s use of a modern contraceptive method and 
cervical cancer screening com- pared to an ART clinic that did not implement SRH 
integration [43]. Similarly, a non-randomized study in Kenya found that a one-stop same-
day integrated family planning and HIV care model was associated with increased use of 
modern contraception but not a reduction in pregnancy incidence among HIV-positive 
women compared to a non-integrated service delivery model [44]. Data from a rigorous 
randomized trial comparing integrated vs. non-integrated contraception and HIV services 
in public-sector HIV clinics in Nyanza, Kenya, found that integration of services was cost-
effective [29], and potentially could provide an opportunity to enhance men’s active 
involvement in contraceptive decision-making [45]. 
 
SRH-HIV integration studies that simultaneously address both the contraceptive and safer 
conception needs of HIV-positive women and men are lacking. In this paper, we describe the 
results of a Phase II futility trial that evaluated an integrated one-stop shop provider-
delivered SRH and HIV intervention, Emtonjeni (spring of knowledge). The intervention 
aimed  to  increase  consistent condom use among HIV-positive people seeking to avoid 
pregnancy and uptake of safer conception services among those seeking pregnancy within 
public-sector HIV care services in Cape Town, South Africa. 
 
Methods 
Study Setting 
The study was conducted in South Africa, a country with one of the highest burdens of 
HIV in the world, with an estimated 6.4 million people living with HIV/AIDS at the end of 
2012 [46]. For many, infection occurs prior to and/ or during peak reproductive years, and 
the epidemic has continued to be marked by pronounced gender differences. HIV 
prevalence among women and men aged 15–49 years is 23.3 %, and 13.3 %, respectively 
[46]. The national contraceptive prevalence is approximately 65 % among sexually active 
women based on the 2003 Demographic and Health Survey data [47]. 
 
HIV prevalence among pregnant women attending public sector facilities in the Cape Town 
Metropole District was 20.0 % in 2012, slightly higher than the 17.8 % overall provincial 
prevalence among pregnant women, but lower than the 29.5 % national HIV prevalence 
[48]. HIV prevalence in Cape Town among pregnant women was 24.6 % among those 
30-34 years old, 22 % among those 25–29 years old, and 13 % among those 20–24 years 
old [49]. Risk of mother-to-child transmission has continued to decline in South Africa, from 
approximately 20 % a decade ago to 2.4 % at birth in 2012 [50]. South Africa’s fertility rate 
has declined as well, from 2.92 in 2001 to 2.35 in 2011, and in the Western Cape, from 
2.36 between 2001 and 2006, to 2.27 between 2006 and 2011, and to 2.19 between 2011 
and 2016 [51]. 
 
 
http://repository.uwc.ac.za
4 
 
Interventions 
Description of the Enhanced and Standard of Care Interventions 
The Enhanced Intervention (EI) was targeted to persons newly diagnosed with HIV, who 
often are highly dependent upon health care providers (including physicians, nurses and 
counselors) for guiding them to optimal health. As gate-keepers of information, providers 
can help to ensure that clients have access to effective contraception and safer conception 
strategies [52]. However, numerous studies have reported that HIV providers do not routinely 
engage PLWH in discussions about contraception and fertility  desires [35, 36, 53–61], while 
clients rarely initiate such discussions with providers [27, 60]. Barriers to providers’ 
discussion of safer conception options include assumptions of HIV sero-concordance, 
limited knowledge of safer conception, weighing reproductive rights versus personal views 
toward PLWH having children, and concerns about delivering customized safer sex 
messages within the context of time constraints [61]. Therefore, we designed and tested a 
provider-delivered intervention in which HIV providers were trained to deliver integrated 
SRH and HIV care services. 
 
The Standard of Care (SOC) intervention condition consisted of three 30–45 min-
counseling sessions delivered by trained peer HIV counselors. Sessions were held within the 
first few months of entry into HIV medical monitoring. At the time the study was 
conducted, this was a routine clinic procedure for orienting patients to HIV treatment, 
fostering disclosure prior to receipt of ARV, and promoting the importance of adherence to 
medication and safer sex guidelines. Following HIV testing and post-test counseling, HIV-
positive individuals were referred to an HIV care clinic. The interval between receiving HIV 
test results and seeking HIV care ranged from one week to six months for the majority of 
HIV-positive persons. Upon entering HIV care, clients  attended two  ‘‘triage’’ visits.  At the  
initial visit, clients had their blood drawn for CD4 testing, received a brief introduction to 
HIV services, and returned to the clinic approximately 3–4 weeks later for clinical staging 
and receipt of their CD4  lab results.  
 
The EI was designed to enable HIV-positive women and men to make informed decisions 
regarding the risks, benefits and options associated with safer sex, contraceptive use, 
fertility, and parenting options. It also consisted of three sessions and covered HIV 
basics, treatment issues, the importance of adherence and suggestions for increasing 
adherence, safer sex, and disclosure of status to significant others. The structure of the EI 
in part was determined by our decision to construct an intervention that would use 
existing staff and involve a similar time commitment (number of sessions) to match the 
organization of services in the SOC, thus minimizing system burden and optimizing potential 
sustainability. With the myriad needs confronting newly-diagnosed HIV-positive 
individuals, a three-session intervention, conducted within the context of a strained 
health care system, cannot address all issues. Our decision to involve both nurses 
experienced in family planning and HIV peer counselors was determined collaboratively 
during our intervention developmental work with them, particularly with regard to their 
comfort and sensitivity about topics. In the EI,  the nurses provided participants with 
contraceptive methods requiring a medical provider to dispense (oral and injectable 
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contraceptives; emergency contraception). The nurses also provided basic SRH counseling 
to all participants, and focused on topics that entailed more medical information such as 
types of contraception, termination of pregnancy and safer conception strategies. 
Participants interested in termination of pregnancy and  voluntary sterilization would  be 
referred for services. Men were invited to refer or come with their partner for these 
services, and all men received individual SRH counseling, whether or not a partner 
attended. Clients saw the nurse at the time of their first and third sessions and had the option 
whether or not to see the nurse at the time of their second peer counseling session. HIV 
counselors also delivered three sessions of the same duration following a scripted protocol, 
with the addition of modules addressing mental health issues, partner violence, and 
availability of supportive services. With the use of a standardized counseling flip chart 
designed for the study, we provided counseling tailored to participants’ reproductive goals, 
whether contraception or safer conception, that took into account participants’ 
partnership types and, if known, awareness of partner(s’) HIV status. 
 
At the first visit, the point of entry into the HIV care system, all clients received a basic 
information and education package to orient them to future health (e.g., TB, nutrition, 
mental health issues), and the HIV peer counselor reviewed issues pertinent to staying 
healthy and treatment options, as well as explored clients’ interpersonal situations (family 
structure and sexual relationships and ease with which to disclose status), including 
sources of support and referral needs. Clients provided a blood specimen for CD4 testing 
and clinical staging. At the second visit (3 weeks after the first visit), in addition to triage 
to further medical services based on the results of the CD4 test, clients received 
individualized specific SRH  counseling by the peer counselors using an interactive 
provider-client flip chart tool designed for the study. These initial sessions with the HIV 
counselors concluded with the development of an ‘Action Plan’ to address client-identified 
needs. After a goal was  identified, and possible barriers and solutions explored, peer 
counselors worked with the client to concretize behavioral steps needed to attain their 
goals (e.g., a goal might be disclosing their status to their mother; the Action Plan would 
include consideration of when, where and how this would be done). At the end of Session 2, 
and during the entire third session, the peer counselor reviewed and supported progress on 
the prior Action Plans, helped clients revise the plans if needed, and develop additional 
plans as new issues emerged. 
 
Male and female condoms were freely available to participants in both conditions. 
Progestogen-only injectables are the most commonly provided contraceptives in South 
Africa [62]. Implants, intrauterine devices, the diaphragm, and combined hormonal 
transdermal contraceptive patches,  and diaphragms were  not available in the public 
sector in South Africa at the time of our study [62]. 
 
All EI participants were given basic information on safer conception methods and asked to 
consult further with the counselor and nurse if they were planning to conceive. EI 
participants interested in conceiving were counseled by the nurses on various ‘‘lower-tech’’ 
approaches for minimizing risk, including stabilizing health; timed intercourse (un- 
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protected sex limited to the ovulatory period and thus peak fertility time); and manual 
vaginal insemination of semen [63–66] by partner or self via sterile needle-free syringes, 
with participants instructed on use and provided with materials and offered syringes, 
where relevant. Periconception [66, 67] and post-exposure prophylaxis [68, 69] and 
treatment as prevention, i.e., use of ART to suppress viral load of the positive partner [70], 
were not available in the public sector during the study period. 
 
We addressed the structural context in which HIV care was delivered in the EI in two ways. 
First, we provided a one-stop shop for contraception and conception services. The co-
location of contraceptive services within an HIV care clinic aimed to mitigate the structural 
barriers to study participants’ access to contraception. Second, the EI also included a 
milieu intervention with clinic staff to foster an HIV and SRH friendly-environment. 
Technical support with clinic staff was ongoing and provided where needed during the 
intervention. The milieu training aimed to help staff confront personal biases and 
misinformation that can stigmatize and alienate their HIV-positive clients, and to ensure 
that the clinic was characterized by a compassionate stance toward clients; it was grounded 
in a human rights perspective and an understanding of the challenges faced by HIV-
positive persons. The milieu intervention involved all staff—from cleaners and clerks to 
physicians—and was framed as a half-day staff ‘retreat’. A critical focus involved values 
clarification to explore beliefs and values about HIV-positive clients and their treatment, 
and ways to decrease barriers and address continued challenges in providing non-
judgmental, supportive services. Following this training, technical and ongoing SRH 
training was provided to the peer HIV counselor-family planning nurse teams who would 
deliver the EI to clients and to medical providers at the clinic, covering contraceptive 
methods, safer conception and sexual risk-reduction counseling. Table 1 provides a 
comparison of EI and SOC interventions. 
 
Development and Content of Flip-Chart Tool 
The client and milieu components of the EI intervention were designed by the HIV Center, 
University of Cape Town, and City of Cape Town and Western Cape Departments of 
Health investigators and subsequently reviewed by an Intervention Development Work 
Group (IDWG) comprising individuals from the Departments of Health and non-
governmental organizations (NGOs) with expertise  in  HIV  prevention,  HIV  treatment  
and  care, gynecology and obstetrics, and nursing and clinical and program staff from 
several NGOs. 
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Peer HIV counselors similar to those who would deliver the EI counseling also were 
involved in the IDWG. We adapted information from the World Health Organization 
Decision-Making Tool for family planning women clients and providers [71] and the 
Western Cape AIDS Training, Information and Counselling Centre (ATICC) for HIV-
positive women and men. Separate flip-chart tools were developed for women and men. 
Materials were subsequently reviewed by IDWG teams, based on internal consensus 
regarding their relevance and applicability. Comments were sent and discussed at a 
meeting. 
 
A Scientific Expert Panel comprising seven international experts on contraceptive 
technologies, HIV treatment, prevention and care, obstetrics, assisted reproduction, and 
bioethics was charged with critically reviewing and advising on intervention messages, and 
served as the final arbiter in determining the appropriate outcomes for HIV-positive 
persons who want or are open to the possibility of having children. They also reviewed all 
intervention materials developed by the IDWG to ensure that they adhered to stipulated 
guidelines and reflected up-to-date medical information. Safer conception counseling, 
rooted in a patients’ rights perspective, focused on options for reducing transmission risk 
to partner and child, including pre- and post-exposure prophylaxis [68, 69, 72], treatment 
as prevention [70], and ‘lower-tech’ safer conception approaches (timed intercourse and 
manual self-insemination with partner sperm) [35, 64, 65], reflecting best practices for 
resource-constrained public-sector settings. Following the development of the flip-chart 
tool, the tool was reviewed and further edited by several provincial health department 
nurses and the study’s HIV counselors. 
 
In the EI, peer HIV counselors used a standardized flip-chart to counsel both women and 
men, and nurses used separate, gender-specific, flip charts to counsel women and men. 
Flip-charts had graphic illustrations on the side viewed by clients and ‘‘scripted’’ counseling 
messages on the side viewed by the counselors and nurses. Scripts were tailored to the needs 
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of individual HIV-positive clients, and aimed to enhance the counseling skills of the peer 
HIV counselors and nurses. Content areas included living a healthy lifestyle with HIV, 
disclosure strategies, stigma, psychosocial challenges and potential violence and SRH 
issues such as: (1) HIV safer-sex strategies, including communication and sexual 
negotiations with partner(s); (2) contraception and HIV, including interactions between 
some ART medications and hormonal methods; (3) fertility decision-making options, 
including effects of HIV on pregnancy and vice versa (4) infertility in HIV-positive 
women and men; and (5) sexual functioning and health. The tool was translated from 
English into isiXhosa, and back-translated into English. We developed a ‘Tracking Sheet’ 
that allowed counselors and nurses (tailored to issues they dealt with) to easily identify and 
follow-up on participants’ Action Plans at subsequent visits. 
 
Study Design 
We used a Phase II non-superiority or futility proof-of-concept design to evaluate whether 
the EI has the potential for being superior to the SOC so that we could bring it forward 
for a Phase III confirmatory study. We chose the futility trial design because it allows for 
screening out ‘‘futile’’ or non-promising interventions, i.e., those that are unlikely to be 
feasible or to demonstrate effectiveness in a Phase III trial [73], in a fairly rapid and 
economical manner, or to recommend further study of the target intervention when 
findings provide encouraging evidence in support of an intervention, a goal that cannot be 
achieved with a typical pilot study design. Results of Phase II non-superiority studies enable 
one to determine, using fewer study participants and shorter-term outcomes, whether a more 
costly and far larger Phase III trial should be undertaken [74]. 
 
In this study, we defined the ‘‘superiority of interest’’ of the EI as improvement in our major 
outcome—adherence to safer sex/safer conception guidelines—exceeding that of SOC by 10 
% points. We chose this value because we believe 10 % is the minimal clinically 
worthwhile improvement that would result in reductions in HIV transmission were the EI 
to roll out on a larger scale. With this design, the null hypothesis is that EI is superior to SOC 
(i.e., the differential in improvement between EI and SOC is at least 10 % points). 
Therefore, if the null hypothesis is rejected, we conclude that there is no evidence of a 
potential benefit of the EI, and a more rigorous test should not be pursued. Conversely, if 
the null hypothesis is not rejected, we cannot rule out the possibility that the EI is truly 
worthwhile, and that further confirmatory testing would be of interest. This is a relatively 
strong position to be in: with a conventional test of the null hypothesis of no efficacy, when 
we do not reject the null hypothesis, possibly due to inadequate sample size, typically one 
would say that we could not rule out ‘‘chance’’ as the explanation for any observed 
differences; and enthusiasm for further testing would be sharply dampened. In the 
futility trial, however, failure to reject the null hypothesis suggests that the intervention is 
either promising enough on the face of it to continue testing, or it is at least insufficient to 
disqualify the intervention from further examination [75, 76]. 
 
We did not choose the typical pilot study design for this study because it usually aims to 
understand the feasibility and acceptability of the intervention as well as to collect 
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mission-critical parameters, such as the recruitment rate, retention rate, and standard 
deviation for the primary outcome, etc. Without requiring a large sample size, a typical 
pilot study allows us to locate the mission-critical parameter approximately, but adequately, 
for planning the subsequent trial; however, statistical power will generally be inadequate 
for testing study hypotheses in a pilot study. 
 
Our study sites were four public-sector HIV care clinics in Cape Town. These clinics serve 
low-income individuals from the surrounding townships. Clinics were pair-matched on 
size [medium and large], HIV-positive client caseload, geographic location and 
demographic characteristics of clients. The two clinics within each pair were randomized to 
either the three-session provider-delivered EI or SOC provider-delivered intervention 
condition by the study’s statistician, who was blinded to the participating clinics, using a 
computer-generated random numbers table. 
 
To minimize the potential for contamination, we asked the EI interventionists (nurses and 
peer HIV counselors) to refrain from sharing intervention materials or discussing specific 
content outside of their clinics for the duration of the study. Since EI and SOC sites were 
geographically separate, we expected minimal, if any, dissemination of information by 
either staff or clients across clinics. Even in the event that information was shared, the 
information alone could not replicate the training and support provided to EI clinics in the 
context of provider training and the milieu intervention. 
 
Statistical Analyses 
Following intent-to-treat principles, we tested the null hypothesis H0:PEI - PSOC ≥ 0:10 
using a generalized linear model, with identity link function and the method of generalized 
estimating equations (GEE) was employed to account for the effect of clustering within 
clinic. We used Rubin’s [77] multiple imputation method, with five repeated imputations, 
to impute the missing endpoints. The final estimate of intervention effect was the average 
of the estimate obtained from the five completed data sets, and the standard error of the 
final estimate was calculated using Rubin’s formula. In secondary analyses, we explored the 
impact of EI on key secondary outcome variables, such as uptake of contraceptive use, to 
help us understand in what ways the intervention affected such outcomes. For these 
analyses, we calculated the means and standard deviations for continuous variables and 
proportions for categorical variables; we did not conduct hypothesis testing since the main 
focus in this case was to highlight information that can be used to plan a subsequent Phase 
III trial rather than to conduct confirmatory comparisons, for which this study was not 
powered. Analyses for this study were conducted using the PASW SPSS ver. 18.0 (SPSS 
Inc., Chicago, IL, USA) and SAS (version 9.3; SAS Inc., Cary, NC). 
 
Sample Size and Statistical Power 
As noted above, we defined superiority as an improvement of 10 % points in the  
intervention  success  rate (i.e.,PEI - PSOC ≥ 0:10, or D = 0.10) in increasing adherence to 
safer sex/safer conception guidelines of EI over SOC. We anticipated the intra-cluster 
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correlation coefficient (ICC) was no greater than 0.003 and calculated the statistical power 
for the study under the design alternative of no difference. 
 
Under the futility design, the type I error is the probability that we mistakenly declare 
the EI has no impact when in reality it is truly beneficial. We set the type I error at 0.10 
as is conventional in proof-of-concept trials [75]. Note that this choice of type I error is 
conservative, as it increases the probability of rejecting the null hypothesis and therefore 
it becomes more difficult to conclude there is potential effectiveness of EI over SOC 
(compared to the 0.05 level typical for Phase III trials) [76]. 
 
 
 
The statistical power for the primary analysis under various assumptions regarding the SOC 
success rate, the intervention effect size, and attrition rate are shown in Table 2. With those 
assumptions, a total sample size of 200 (100 per group) allowed for adequate power (i.e., 80 
% or more) to declare the EI futile if the success rate for EI equals that of SOC. 
 
Study Population and Recruitment 
We targeted our intervention to recently diagnosed HIV-positive persons as they entered 
the HIV care system. Since ART had only begun to be extensively rolled out at the time of 
intervention start-up, there were more ARV-na ı¨ve people in HIV care medical monitoring 
at that time. Due to the Department of Health expanding opportunities for HIV testing at 
all public sector health visits, numbers of clients entering HIV care pre-ART increased, but 
there was no concomitant in-depth counseling or ongoing service provision at this entry 
point into the HIV care continuum compared to settings such as ART services. We recruited 
HIV-positive women and men in the clinic waiting room between August 2010 and August 
2011. Prior to their receiving their CD4 cell count results, a clinic nurse gave clients an 
Information Sheet describing the study (as one about SRH services for HIV-positive women 
and men aimed at increasing understanding of how to improve the quality of these services 
within the HIV care system). Those who were interested were referred to research staff who 
were not employed by the clinic for additional information. 
 
To be eligible for the trial, participants had to be HIV-positive, C 18 years, attending the 
clinic to receive their first CD4 cell count results since testing HIV-positive, not on ARVs, 
not pregnant, reporting unprotected vaginal or anal sex in the prior three months and/or 
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considering conceiving within the next six months. These criteria were selected because our 
intervention focused on both avoidance of pregnancy and adherence to safer conception 
guidelines among HIV-positive individuals who were trying to conceive. 
 
Figure 1 provides an overview of study flow. Interested individuals  discussed  the  study   
with   research   staff (N = 327); of those, 68 (20.8 %) declined to be screened for 
eligibility. This was primarily due to time constraints (N = 56; 82.4 %). There were no 
gender differences between those who agreed to be screened and those who did not (p = 
0.45). Of 259 HIV-positive women and men who were screened, 17.4 % were ineligible. 
We enrolled 108 women and 106 men (N = 214) who completed the Baseline (BL) 
interview; 184 (86.0 %) completed the Follow-Up 1 interview (FU1) and 166 (77.6 %) 
completed the Follow-Up 2 interview (FU2). One hundred and ten participants received 
counseling in a clinic randomized to the SOC, and 104 received counseling in  a clinic 
randomized to the EI. There were no significant differences in attrition by condition. 
 
Informed consent (including access to medical records) was obtained from all interested 
eligible clients. The study was approved by the Institutional Review Board at the New York 
State Psychiatric Institute-Columbia University Department of Psychiatry and the Human 
Research Ethics Committee of the University of Cape Town. 
 
Data collection 
Face-to-face interviews were conducted in isiXhosa or English, according to client 
preference, in privacy in the clinic, by experienced gender-matched interviewers who were 
blind to condition. The BL interview was administered after participants’ receipt of CD4 
cell count results, except for 8 participants, who completed this interview within one 
month of receiving their results. FU interviews were conducted at three months (FU1) 
and six months (FU2) after the initial interview. Participants received 50 rand ($7.00 US 
at time of study) for completing the BL interview, 80 rand ($11 at time of study) for the 
three-month FU1 interview, and 100 rand ($14 at time of study) for the six-month FU2 
interview. 
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To evaluate the impact of the intervention on clinic milieu, we also conducted anonymous 
exit interviews with clinic clients not enrolled in the trial in the waiting area to assess their 
perceptions of the clinic environment at base-line before the intervention started (N = 376; 
approximately 94 patients per clinic), and one year later (N = 306, approximately 76 per 
clinic). No reimbursement was provided to participants for these exit interviews. 
 
Measures 
Primary Outcome 
The  goal  of  this  study  was  to  foster  safer  conception among  those  seeking  to  conceive  
and  to  promote  dual protection—simultaneous  prevention  of  pregnancy  and STI 
transmission—among those wishing to  avoid  pregnancy. Therefore, the primary outcome, 
specified a priori, was captured by  a binary indicator reflecting a participant’s safer 
sex/safer conception behavior. We considered the outcome as a ‘‘success’’ if, at FU2, a 
participant wishing to avoid pregnancy reported no condom-unprotected sex, or if a 
participant wishing to conceive followed safer conception guidelines. Intent to conceive was 
based on a ‘yes’ response to the question, ‘‘Are you thinking  about   trying   to   have   a   
child   in   the   next 6 months?’’ 
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Our decision to define the pregnancy prevention outcome in this way was because relying 
on a hormonal contraceptive without condom use ignores the health risk of STI 
transmission between partners, a sub-optimal public health outcome. The intervention 
emphasized safer conception approaches among those wishing to conceive that would 
minimize STI/HIV exposure for the uninfected partner. 
 
Clinic-Level Outcome 
Perceptions of the SRH-‘friendliness’ of the clinic milieu among non-enrolled clients were 
assessed using a 40-item measure with agree or disagree response options (sample items: 
It’s not safe for clients to discuss their personal problems around here; There are good 
educational materials on HIV available for free; Staff members dislike the clients who use 
this service in this clinic; Clients are rarely kept waiting when they have appointments with 
the staff in this service; The staff go out of their way to help clients (Cronbach’s alpha = 
0.77). 
 
Secondary Outcomes 
These included sexual behavior and contraceptive use variables focused on behavior 
during the prior three-month period: number of condom-unprotected sex occasions, 
percentage of condom-protected sex occasions, whether dual method protection was 
used (i.e., condom plus an additional contraceptive), and whether all vaginal sex 
occasions were protected by an effective contraceptive (condoms, sterilization and/or 
hormonal contraceptives). We also examined changes in intention for consistent 
condom use (How likely is it that you will use a male or female condom every single time 
you have vaginal sex in the next 3 months? Would you say very unlikely, unlikely, likely, or 
very likely?); safer-sex self-efficacy, a 13-item scale with a four-point Likert response 
format assessing confidence in ability to engage in safer sex behaviors (sample item: 
How confident are you that you could use a male or female condom every time you have 
sexual intercourse with  (a/your)  regular  partner(s)  in  the  next 3 months? Would 
you say very unconfident, somewhat unconfident, somewhat confident, or confident? 
(Cronbach’s alpha = 0.79); and self-efficacy for communicating with partner about safer 
sex and SRH, a 9-item scale using a four-point Likert response format (sample item: 
How confident are you that you could convince (a/your) regular partner(s) in the next 3 
months to use condoms? (Cronbach’s alpha = 0.61) using the same response format. All 
three measures had a range of 1-4, with higher scores reflecting the more desirable 
outcome. We also evaluated whether participants disclosed their HIV-positive status to 
their primary partner. 
 
Reliability and Validity of Self-Reported Sexual Behavior and Contraceptive 
Use Measures 
Although much debate has centered on the reliability and validity of self-reported sexual  
behavior to  evaluate intervention  effectiveness,  there  is  evidence  supporting the  validity  
of  self-reported  condom  use  from  studies using biological markers of STI incidence or 
HIV seroconversion [see 78–82]. We took particular care in constructing sexual risk 
behavior and contraceptive use measures  to  minimize  social  desirability  bias   (see [83, 
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84]). We used a semi-structured interview format that builds on interviewing techniques 
identified by sexual science that initially emerged from Kinsey’s work [85]. Participants 
were interviewed by gender-matched interviewers, and we used normalizing prefaces that 
frame sensitive behavior as normal, which evidence suggests can result in greater 
disclosure of unsafe behavior [86]. Specifically, questions about actual behavior were 
preceded by short paragraphs providing prefaces that normalized occasional non-use of 
condoms, and normalized desire to have children among PLWH. After the normalizing 
preface on condom use, participants were asked if they had ever failed to use or misused 
condoms for each of several reasons (e.g., there was no condom available; you got ‘carried 
away’; the condom was put on after sex started—before ejaculation, but after penetration), 
and, if so, whether that had occurred in the prior three months. 
 
Results 
Demographic and Reproductive Health Characteristics of Sample 
Demographic and reproductive health characteristics of the baseline sample by 
intervention condition are shown in Table 3. Median age was 29, and median number of 
years of schooling was 11. Slightly more than half of participants reported some form of 
employment, predominantly self-employment in the informal sector, and 70 % resided in 
an informal dwelling. About three-fourths had been diagnosed with HIV within the prior 
year, and median CD4 count at baseline was 414. Almost all participants had someone 
they identified as a current main partner, with less than half living with that partner. 
Nearly two-thirds (64.1 %) had disclosed their HIV-positive status to their main partner. 
Median number of biological children was 1, and median number of children cared for 
was 2. Almost all (98.1 %) participants were sexually active, and 82.5 % reported 
unprotected sex in the prior three months. Nearly two-fifths indicated that they/their 
partner used a hormonal contraceptive (pill or injectable) in the prior three months, 32.2 
% had used dual-method protection, and 52.1 % reported that all vaginal sex occasions 
were protected by effective contraception. Forty-three percent were considering conceiving a 
child in the  near  future,  and  nearly  a  third  indicated  that  their main  partner  was  
similarly  interested. Self-efficacy for safer sex and for communicating with a partner  about 
safer sex and reproductive health was fairly high (3.7 on a 4-point scale). There were no 
significant differences in any sample characteristics between conditions. 
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Primary Analysis 
In the primary analysis, we did not reject the null hypothesis that the ‘‘success’’ rate 
for EI exceeded by 10 % or more the success rate of SOC, i.e. PEI – PSOC ≥ 0:10  
(PSOC = 0.72,  PEI = 0.83,  PEI - PSOC = 0.11, 95 % CI -0.04, 0.27), p = 0.58). This 
indicates that we cannot rule out the possibility of EI being a truly effective intervention 
for promoting safer sex and safer conception. Findings were similar for men (PSOC = 
0.76, PEI = 0.87, PEI - PSOC = 0.11,  95 % CI (-0.05,  0.28), p = 0.57) and   
women   (PSOC = 0.67,    PEI = 0.78,    PEI - PSOC = 0.11, 95 % CI (-0.11, 0.33), p 
= 0.53). 
 
Secondary Analyses 
We did not conduct hypothesis testing for secondary outcomes; therefore, no p values are 
reported. Instead, we provide descriptive statistics (i.e., the means and proportions) to 
help understand the direction of EI intervention effect on key secondary outcomes and 
we did not and should not declare or suggest any findings from secondary analysis as 
statistically significant. Considering the clinic-level outcome (perceptions about the clinic 
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milieu), the following cross-sectional estimates were observed at baseline and 12-month 
follow-up: baseline: SOC = 3.13, EI = 3.11;  FU2:  SOC = 2.82,  EI = 3.16).  Longitudinal 
(individual-level) data are reported for secondary outcomes, according to condition and 
time point in Table 4. (The change over time for those outcomes can be obtained by simply 
subtracting BL from FU values and therefore are not presented in the table.) Participants 
receiving EI counseling reported greater improvement from baseline to FU1 and from 
baseline to FU2 on percentage of condom-protected sex occasions (SOC: 33 % increase 
from BL to FU1 and 39 % increase from BL to FU2 vs. EI: 51 % increase from BL to FU1 
and 53 % increase from BL to FU2); fewer unprotected sex occasions (SOC: decrease of 
approximately 10 unprotected sex occasions at FU1 and FU2 vs. EI: decrease of 
approximately 17 unprotected sex occasions at FU1 and FU2); and intention for consistent 
condom use (group difference in average change over time on a four-point scale: SOC: .07 
increase from BL to FU1 and .24 increase from BL to FU2 vs. EI: .52 increase from BL to 
FU1 and .49 from BL to FU2). EI participants also showed greater safer-sex self-efficacy at 
FU1 (average change over time on a four-point scale: SOC: .05 decrease from BL to FU1 and 
.09 decrease from BL to FU2 vs. EI: .07 increase from BL to FU1 and .04 decrease from BL 
to FU2), although both groups saw a slight decrease in rating partner communication self-
efficacy (average change over time on a four-point scale: SOC: .0 decrease from BL to FU1 
and .11 decrease from BL to FU2 vs. EI: .06 decrease from BL to FU1 and .06 decrease from 
BL to FU2). 
 
 
 
There were greater increases among EI participants in the proportion of participants  
reporting  dual-method  protection (i.e., using condoms plus another contraceptive) (SOC: 
an additional 11 % reported use at FU1 and approximately 12 % additional users at FU2 
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vs. EI: an increase from BL to FU1 of 29 % and approximately 22 % increase from BL to 
FU2), whether all vaginal sex occasions were protected by an effective contraceptive (SOC: 
a 29 % increase from BL to FU1 and a 22 % increase from BL to FU2 vs. EI: a 46 % increase 
from BL to FU1 and a 43 % increase from BL to FU2). More participants in the EI 
condition had disclosed their HIV status to their main partner by first follow-up (SOC: 
67.8 % vs. EI: 76.5 %), although by FU2 the proportion of individuals who had disclosed 
their HIV status was nearly identical in both groups. 
 
In  Table 5,  we  present  the  variables  in  Table 4  by gender.  Men  in  both  conditions  
reported  a  higher  percentage  of  condom-protected  sex  occasions  and  fewer 
unprotected sex occasions at all three time points than did women,  and  a  slightly  higher  
proportion  of  men  than women reported use of 100 % effective contraception at both  
follow-up  assessments.  Across  all  time  points,  a greater proportion of men than women 
had disclosed their HIV status to their main partner. The data suggest that women and 
men did not respond differently to SOC or EI. In a subgroup analysis of those not seeking 
pregnancy at BL (N = 134) (not tabled), those receiving EI counseling had greater 
improvement from baseline to FU2 on whether dual-method protection was used (SOC 44.0 to 
50.0 % vs. EI 33.9 to 42.2 %), on whether all vaginal sex occasions were protected by an 
effective contraceptive including condoms alone (SOC 61.3 to 84.0 % vs. EI 55.9 to 94.7 %), and 
on consistent condom use (SOC 16.2 to 76.0 % vs. EI 10.3 to 86.8 %). 
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Since we lack the statistical power to do meaningful subgroup analysis of those who 
were interested in conceiving by condition, we provide descriptive data. We identified 80 
participants at baseline with intent to conceive (17 women and 63 men). An additional 
three women indicated intent to conceive at the first follow-up interview. Among all 
individuals reporting intent to conceive in the coming 12 months at either baseline or 
first follow-up,  we  had  no  follow-up  data  from  10  men (15.9 % of 63 men). Among 
those with follow-up data, nine women (45.0 %) and 52 men (82.5 %) had decided not to 
seek pregnancy at subsequent follow-up; all but 3 of these participants still desired to 
conceive, but not in the next 12 months (95 % of those with follow-up data). There were 
no  discernible differences by condition. Among the 11 remaining women with pregnancy 
intent at baseline or first follow-up, three did not follow safer conception guidelines, three 
reported 100 % condom use during the subsequent period(s), one reported practicing 
timed intercourse, one sought consultation with a physician before attempting to conceive,  
one  delayed attempting to conceive and was awaiting results of medical  testing,  one  
reported  using  self-insemination  with partner  sperm,  and  one  woman’s  practices  
were  not determinable. The sole man who reported continued interest in conceiving at 
follow-up did not follow safer-conception guidelines. Three of the four women reporting 
safer conception practices at follow-up had received EI counseling, and the woman who 
had received SOC counseling reported having consulted with a physician. Eight participants 
(4 men and 4 women, half of whom received the EI and half SOC) reported a 
pregnancy or partner pregnancy over the course of follow-up. Two of these pregnancies 
were unintended (1 EI woman and 1 SOC woman). Note that although being pregnant at 
baseline was an exclusion criterion, this was assessed by self-report, so it is possible that 
some of these pregnancies occurred prior to the six-month observational period. 
 
Discussion 
This is one of the first trials to assess an intervention that integrated both contraceptive 
and safer conception services into HIV care and treatment. Few  interventions have  been  
implemented  to  promote  contraceptive  use and/or  safer  conception;  moreover,  SRH  
interventions that include HIV-positive men are limited. Unlike integration studies that 
provide SRH services in ARV treatment settings [37, 43], our intervention was targeted 
to newly-diagnosed HIV-positive individuals who were not eligible for ARV treatment at 
time of study recruitment. Our study differs from other rigorously evaluated SRH-HIV 
integration initiatives by our focus on both dual protection and safer conception, our 
inclusion of a clinic-level component to improve the ‘reproductive health friendliness’ of 
the clinics, and provision of SRH services to men. 
 
Results from the primary analysis of this proof-of-concept study, using a futility design, 
showed that the enhanced intervention has merit. We were unable to reject the null 
hypothesis that EI is superior to SOC by at least 10 % points. Eighty-three percent of 
participants who received the EI vs. 72 % of those receiving SOC followed safer sex or safer 
conception guidelines at follow-up. The results indicate that a larger-scale confirmatory 
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study to test whether the EI is indeed superior to SOC, perhaps using a clinic-based, cluster 
randomized controlled design, is of interest. 
 
Since this Phase 2 trial was not powered to evaluate secondary outcomes, we reported 
these as exploratory findings only. Those analyses provided a suggestion of potential 
greater improvement among those receiving the EI (vs. SOC) in consistent condom use, 
percent reliance on condoms, safer sex self-efficacy, self-efficacy for communicating with 
partner, and decreased condom-unprotected sex. Subgroup analyses examining dual 
method protection and effective contraceptive use among those seeking to avoid 
pregnancy were also in the expected direction, with a greater proportion of those in the EI 
group reporting consistent use of effective contraception than the SOC group. Descriptive 
data on participants who were interested in getting pregnant in the near future 
indicated fairly high interest at baseline (43 % of participants and 29.6 % of their 
partners), although most (95 % of those with follow-up data) decided to postpone plans for 
getting pregnant to the following year. It may be that discussion about the benefits of 
stabilizing health before seeking pregnancy, recommendations by counselors to avoid 
unprotected sex, or simply that the reality of health challenges struck home after 
participants first enrolled in HIV care, giving pause to participants’ pregnancy timeline. 
Because of shifting rates of pregnancy intent at follow-up, most of the change in our major 
outcome (following safer sex or safer conception guidelines) was due to decreases in 
condom-unprotected sex and increases in condom use. Due to the small sample size, we 
could not meaningfully evaluate differences by condition among those seeking pregnancy 
at baseline or follow-up. 
 
It is unclear what the differences in EI and SOC client perception of the clinic milieu 
mean, since within condition, ratings of milieu in EI clinics were stable whereas ratings 
at SOC sites significantly decreased.  
 
We note a number of limitations. All persons screened for eligibility were interested in 
participating in a study of SRH, and among the total screened sample, only 8.6 % of men 
and 22.2 % of women reported neither pregnancy intent nor unprotected  sex,  which may 
be  atypical, although other studies have found similar rates of pregnancy intent among 
HIV ? women [87, 88] and men [27]. The 76 % of screened participants reporting 
unprotected sex is similar to the estimate of approximately 74 % found in a prospective 
study of HIV-positive women in South Africa [15]. These are similar to the baseline levels of 
79 to 83 % found in a study of HIV-positive women in Kenya that evaluated contraceptive 
service integration [29]. A further limitation is reliance on self-reported outcomes, with the 
attendant issue of social desirability. While bias should be similar in both study arms, 
given similar intensities of counseling in EI and SOC and no differences between 
conditions on all reproductive health characteristics at baseline, EI participants could be 
more likely to over-report condom use because the intervention emphasized condom use. 
However, we believe that the way we assessed sexual behavior and pregnancy intent 
helped to increase willingness to disclose stigmatized behavior. Finally, our intervention 
was targeted to newly-diagnosed HIV-positive individuals who were not eligible for ART at 
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time of recruitment; with the new WHO guidelines of treatment for all, there is a need to 
revise the content of our counseling to fit the needs of HIV-positive people who initiate 
ART. 
 
With recognition that choices about fertility among PLWH is a basic human right, 
strategies for helping them realize their reproductive goals must remain a priority [1–3]. 
Issues of childbearing and safer conception can no longer be sidelined in public health 
policies and clinical practice. The need for integrated SRH services for PLWH that address 
STI prevention, contraceptive and conception needs, as well as models that attend to multi-
level patient and provider factors [89] are reflected in high HIV-related maternal mortality 
in South Africa, where 34.7 % of maternal deaths were due primarily to AIDS and other 
non-pregnancy-related infections [90, 91] and high HIV prevalence among reproductive-
aged women. 
 
Interventions to promote safer conception are in their embryonic stages of development 
and implementation. A safer conception service recently launched at a primary health 
center in Johannesburg for HIV-positive women (and their partners) who intended to 
conceive in the coming six months was found to be feasible [92], with most participants 
favoring timed unprotected intercourse, manual insemination and combined ART, and few 
opting for pre-exposure prophylaxis (PrEP). We are unaware of any published clinical trials 
that have examined integration of HIV and true comprehensive ‘family planning’ services 
that address both contraceptive and safer conception needs. Such service integration needs 
to be targeted to both the clinic- or health systems level and individual-level [39]. 
 
Since the end of our study, the landscape of fertility options in public-sector clinics for 
HIV-positive women and men who want to conceive in ways that reduce HIV transmission 
risk to uninfected partners and to infants has been changing in some sub-Saharan 
countries. South Africa has pioneered the development of safer conception guidelines that 
outline higher and lower cost options [93]. These could serve as a model for health care 
providers and counselors in settings where laboratory-based assisted reproduction is 
neither widely available nor affordable. Research in South Africa has documented high 
levels of interest in procreation among PLWH [27, 94, 95] and acceptability of safer 
conception services [64, 94–98]. 
 
‘‘Putting integration into practice’’ is a priority of the South African government. This 
means that evidence-based  SRH  counseling  that  fosters  discussion  of  actual  reproduct 
ive  intent with HIV-positive persons should  be routinely offered for HIV-affected couples 
desiring  children in conjunction with services that promote contraceptive uptake for those 
who do not desire  children in sub-Saharan  Africa. This dual focus is  articulated  in  South 
Africa’s 2012 National  Contraception and Fertility Planning Policy and  Service Delivery 
Guidelines [99]. However, to move   from the theoretical to programmatic 
implementation,  adequate funding to support  such  programs,  standardized counseling 
protocols, and training of health care providers in contraception and safer conception will 
be needed. Other health system issues, such as space, workload, staff supervision, patient 
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flow, and ongoing monitoring and evaluation and accountability, will also need to be 
addressed [39]. 
 
The extent to which health care providers in South African public-sector  clinics  have been  
trained in safer conception and to which safer conception guidelines have been routinely 
implemented in practice is unknown. However, a recent qualitative study with health care 
providers and HIV-affected women and men from one Johannesburg primary clinic 
suggests some knowledge of safer conception methods, but that discussions about fertility 
planning were initiated by patients, not providers, thus reflecting non-optimal 
implementation of the guidelines [100]. In a study in two Durban ART clinics, providers 
expressed discomfort in providing safer conception services to HIV-serodiscordant 
couples [101], and in another Durban study, none of the 35 male and female clients  
reported  receiving  counseling  on  specific  safer conception methods [60]. Similarly, in a 
study in Kisumu, Kenya, providers reported that they did not routinely offer standardized 
preconception counseling messages to HIV-serodiscordant couples [102]. 
 
Conclusion 
In an effort to achieve the UNAIDS 90-90-90 target by 2020, testing promising 
interventions that appropriately address fertility desires of HIV-positive individuals—both 
those who want to avoid or defer childbearing and those who want to conceive—within 
the context of real-world, overburdened and under-resourced, public-sector clinic settings 
is essential for determining their readiness for scale-up. Results from this trial suggest that 
the intervention has merit and should be more rigorously evaluated in a Phase III trial with 
biological endpoints in South Africa and other high HIV burden, resource-constrained 
settings in sub-Saharan Africa. This is all the more important as countries move toward 
universal treatment of HIV-positive people, irrespective of their CD4 count and HIV viral 
load. 
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